The settlement comes nearly three years after the company acknowledged that an industrial foam fitted inside its machines ...
The FDA published a warning letter that it sent to Philips (NYSE:PHG) that outlines issues around imaging technology ...
Federal Court Enters Consent Decree Against Philips Respironics Following Recall of Certain Sleep Therapy Machines ...
The recall ultimately grew to include about 5. ... the increased scrutiny will help us to improve even more,” said Philips CEO Roy Jakobs. “With the agreement on a consent decree for Philips ...
CEO Roy Jakobs in January noted on ... Under the terms of the agreement, Philips Respironics will continue the recall. The company said that more than 99% of the sleep therapy devices have been ...
Decree comes amid the FDA’s 2021 inspection of Philips’ Murrysville facility and the subsequent voluntary recall of its sleep ...
Under the consent decree, Philips (PHG) Respironics will continue to prioritize completing the remediation of the sleep and respiratory care devices under its voluntary 2021 recall. Philips (PHG ...
The company responsible for a global recall of sleep ... Phillips CEO Roy Jakobs issued a statement saying, "Strengthening patient safety and quality remains Philips' highest priority and the ...
Under the agreement, the FDA will use rare powers to require repairs, replacements or refunds for recalled respiratory machines.
and Philips Holding USA Inc., and Roy Jakobs, CEO of Royal Philips, along with several other individual defendants named in the decree. The consent decree, with limited exceptions, restricts the ...